Constructing Capabilities: Holistic Infrastructure Development in Decentralized Manufacturing
Industry:
Biopharma
Type:
Podcast
Location:
Miami, Florida
This fifth and final panel with Sean Bartholomew (Biopharma Applications Engineer, Germfree) and Grayson Heller (COO, cGMPnow) discuss the considerations for decentralized cell therapy manufacturing. The key points include the importance of designing identical and cloned processes, focusing on a copy-paste model for multiple locations.
You might also be interested in
Ballad Health Transforms Sterile Compounding with Smarthood
Why Mobile and Modular Cleanrooms are Changing the Game in Bio-Manufacturing
Smarthood™: Setting a New Standard in IV Compounding
Contact us: Let's unlock your scientific potential together
Complete our contact form and a member of our commercial team will contact you within 24 hours.